知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

148 条记录 (耗时 0.056 秒)

    CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF
    1.
    发明公开
    CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF 审中-公开

    公开(公告)号：US20240335559A1

    公开(公告)日：2024-10-10

    申请号：US18579456

    申请日：2022-07-15

    申请人： USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V.V.I.

    发明人： Petr CIGLER ,  Klara GRANTZ SASKOVA ,  Vaclav VANEK ,  Zuzana HEJDANKOVA ,  Lenka LOUKOTOVA ,  Pavel SVEC ,  Anastasiia PRISS ,  Silvia PETREZSELYOVA

    IPC分类号： A61K48/00 ,  A61K8/42 ,  A61K9/127 ,  A61K9/51 ,  C07C233/62 ,  C07C237/10 ,  C07D207/12 ,  C07D311/00 ,  C12N15/88

    CPC分类号： A61K48/0033 ,  A61K8/42 ,  A61K9/1271 ,  A61K9/5123 ,  C07C233/62 ,  C07C237/10 ,  C07D207/12 ,  C07D311/00 ,  C12N15/88 ,  C07C2601/14

    摘要： The present invention relates to a lipidoid of general formula I, wherein X is selected from —C(═O)NH—, —C(═O)O—, —C(═S)O—, —C(═O)S—, —C(═S)S—, —C(═O)NHNH—, —CH2—, —O—, —OC(═O)—, —S—, —SC(═O)—, —NH—, —NHNH—, —NHC(═O)—, —NHNHC(═O)—, —C═C—, —CH═CH—, a five-membered heterocycle containing at least 2 nitrogen atoms, —CH2C(═O)NH—, —CH2C(═S)O—, —CH2C(═S)S—, —CH2C(═O)NHNH—, —N═CH—, —CH═N—, —NH—N═CH—, and —CH═N—NH—; Y is alkylene C2-C10 chain; R1 is selected from alkyl C1-C46, alkenyl C2-C46, alkynyl C2-C46; Z is selected from H, —OH, —CH3, —CH2OH, —NH2, —C(═O)NH2, —CONH(CH2)2OH, —CON[(CH2)2OH]2, —CONHCH(CH2OH)2, —CONHCH2CH(—OH)CH2OH, —CONH(CH2)2C(═O)NH2, —CON[CH2C(═O)NH2]2, —CONH(CH2)2NHC(═O)NH2, —CONH(CH2)3—N+(CH3)2—(CH2)2—SO3—, —CONH(CH2)3—N+(CH3)2—(CH2)2—COO−, —COO(CH2)2—O—P(═O)(O—)—O(CH2)2—N+(CH3)3, —N+(CH3)2—(CH2)3—SO3—, —N+(CH3)2—(CH2)2—COO−, formula (II), and formula (III), wherein R2 is independently selected from hydrogen and —CH3; E is independently selected from O and S atoms; n is an integer within the range of from 1 to 5; and T is selected from —X—Y—N(R1)2, —C(═O)O(C1-C3 alkyl), —C(═O)OCH2CH2OH, formula (IV), formula (V), formula (VI), —C(═O)OH, —CONH(CH2)2OH, —CON[(CH2)2OH]2, —CONHCH(CH2OH)2, CONH(CH2)2C(═O)NH2, —CON[CH2C(═O)NH2]2, —CONHCH[C(═O)NH2]2, —CONH(CH2)2NHC(═O)NH2, —C(═O)NH2, —CONH(CH2)3—N+(CH3)2—(CH2)2—SO3—, —CONH(CH2)3—N+(CH3)2—(CH2)2—COO−, —NH2, —NHC(═O)CH3, —COO(CH2)2—O—P(═O)(O—)—O(CH2)2—N+(CH3)3, —OH, —O(C1-C3 alkyl), —NHC(═O)NH(CH3), —NHC(═S)N(CH3)2, —NHC(═S)NH(CH3), —NHC(═N—CN)NH2, —NHC(═N—CN)NH(CH3), —NHC(═N—CN)N(CH3)2, —NHC[═N—S(═O)2NH2]NH2, —N+(CH3)2—(CH2)3—SO3—, —N+(CH3)2—(CH2)2—COO−, wherein R2, E and n are as defined above; and/or if Z is —OH or —CH2OH, and T is —C(═O)OH, then Z together with T and three carbon atoms between them may form a cyclic lactone containing 4 to 5 carbon atoms; and pharmaceutically acceptable salts, addition salts and solvates thereof. This lipidoid is useful as a transfection agent. The invention further describes transfection reagents, transfection particles containing this lipidoid, and their use.